Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2019

Open Access 01-04-2019

Hospitalization rate in offspring of cancer survivors: a national cohort study

Authors: Jianguang Ji, Wuqing Huang, Jan Sundquist, Kristina Sundquist

Published in: Journal of Cancer Survivorship | Issue 2/2019

Login to get access

Abstract

Purpose

The number of childbirths among cancer survivors continues to increase, but it is still largely unknown whether the children of cancer survivors might experience adverse health outcomes during the process of growing up.

Methods

We identified all individuals diagnosed with cancer between 1958 and 2015 from the Swedish Cancer Registry and linked them to the Swedish Medical Birth Register to identify their offspring born between 1997 and 2015. Up to 10 children, whose parents did not have a diagnosis of cancer, were matched with the study population according to date of birth and gender.

Results

By linking with the Swedish Hospital Discharge Register, we found that the hospitalization rate was 15% higher in offspring of female cancer survivors, and 16% higher in offspring of male cancer survivors as compared to matched controls. Besides an increased risk of hospitalization due to malignant neoplasms (relative risk (RR) = 1.86, 99% CI 1.70–2.04) and benign neoplasms (RR = 1.48, 99% CI 1.18–1.86), a non-significant increased risk was found for hospitalization due to infectious and parasitic disease (RR = 1.09, 99% CI 0.98–1.21), diseases of the blood and blood-forming organs and certain disorders involving the immune mechanisms (RR = 1.33, 99% CI 0.98–1.80), and diseases of the circulatory system (RR = 1.05, 99% CI 0.98–1.12).

Conclusion

Our study suggests that children of cancer survivors might experience a significantly increased rate of hospitalization, which calls for further studies.

Implications for Cancer Survivors

Cancer survivors might be aware that the risk of hospitalization due to various diseases might be higher in their children as compared to the normal population.
Literature
20.
go back to reference Tomar SL, Connolly GN, Wilkenfeld J, et al. Declining smoking in Sweden: is Swedish Match getting the credit for Swedish tobacco control’s efforts? Tob Control. 2003;12(4):368–71.CrossRefPubMedPubMedCentral Tomar SL, Connolly GN, Wilkenfeld J, et al. Declining smoking in Sweden: is Swedish Match getting the credit for Swedish tobacco control’s efforts? Tob Control. 2003;12(4):368–71.CrossRefPubMedPubMedCentral
31.
go back to reference Donkin I, Barres R, Pinborg A. [Epigenetic influence on embryonic development]. Ugeskrift laeger. 2016;178(37) Donkin I, Barres R, Pinborg A. [Epigenetic influence on embryonic development]. Ugeskrift laeger. 2016;178(37)
36.
go back to reference Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109(2):107–14.CrossRefPubMed Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109(2):107–14.CrossRefPubMed
37.
go back to reference Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr. 1992;121(6):880–4.CrossRefPubMed Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr. 1992;121(6):880–4.CrossRefPubMed
41.
go back to reference Izard MA. Leydig cell function and radiation: a review of the literature. Radiother Oncol. 1995;34(1):1–8.CrossRefPubMed Izard MA. Leydig cell function and radiation: a review of the literature. Radiother Oncol. 1995;34(1):1–8.CrossRefPubMed
Metadata
Title
Hospitalization rate in offspring of cancer survivors: a national cohort study
Authors
Jianguang Ji
Wuqing Huang
Jan Sundquist
Kristina Sundquist
Publication date
01-04-2019
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00741-5

Other articles of this Issue 2/2019

Journal of Cancer Survivorship 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine